MOTS-c

MOTS-c stands as one of the most intriguing discoveries in longevity research — a 16-amino acid peptide (MRWQEMGYIFYPRKLR) with a molecular weight of 2.17 kDa that serves as a direct messenger between your mitochondria and cell nucleus. Evidence suggests this mitochondrial-derived peptide discovered in 2015 by [Dr. Pinchas Cohen's team at USC](https://pubmed.ncbi.nlm.nih.gov/26244932/) has captured attention for its unique ability to regulate cellular metabolism and potentially slow age-related decline.

Unlike traditional peptides encoded by nuclear DNA, MOTS-c originates from mitochondrial genes, making it a natural communication molecule that your cells already produce. As we age, some research suggests MOTS-c levels may decline, correlating with decreased metabolic function and physical performance — which is why researchers are investigating it as a potential anti-ageing intervention.

The peptide primarily attracts three groups: longevity enthusiasts seeking to optimise mitochondrial function, athletes looking for metabolic advantages, and older adults hoping to maintain youthful energy levels. What sets MOTS-c apart from other metabolic peptides like [Tesamorelin](/peptides/tesamorelin) or [AOD 9604](/peptides/aod-9604) is its fundamental role in cellular energy production rather than hormone manipulation.

Current evidence, whilst promising, remains largely preclinical. Animal studies demonstrate impressive metabolic benefits — improved glucose tolerance, enhanced fat oxidation, and protection against age-related metabolic dysfunction. Human data is limited to observational studies showing that higher MOTS-c levels correlate with better physical performance in older adults, as demonstrated in [Reynolds et al.'s 2021 study](https://pubmed.ncbi.nlm.nih.gov/34417459/).

The peptide works by activating AMPK, your cellular energy sensor, particularly in skeletal muscle. This triggers a cascade of metabolic improvements including enhanced glucose uptake, improved insulin sensitivity, and stimulation of mitochondrial biogenesis — essentially helping your cells produce more energy factories.

For UK users, MOTS-c occupies the familiar research chemical territory. It's available through various suppliers but lacks MHRA approval, meaning users are essentially participating in self-experimentation. Quality varies significantly between sources, making supplier selection crucial.

Typical protocols involve daily subcutaneous injections of 5-20mg, often cycled in 4-6 week periods. Many users stack it with other longevity-focused compounds like [BPC-157](/peptides/bpc-157) or [Epithalon](/peptides/epithalon) for synergistic effects. Our [reconstitution calculator](/tools/reconstitution) can help determine precise dosing once you've sourced your peptide, whilst our [dosing guidelines](/learn/peptide-dosing) provide comprehensive protocols for optimal administration.

Whilst MOTS-c shows remarkable promise for metabolic enhancement and healthy ageing, remember that comprehensive human safety data doesn't exist. The research is genuinely exciting, but we're still in early days for understanding optimal protocols and long-term effects.

MOTS-c operates through a sophisticated dual mechanism that makes it unique among peptides — studies indicate it functions both in the cellular cytoplasm and can migrate to the nucleus to directly influence gene expression.

The primary action occurs through AMPK (AMP-activated protein kinase) activation in skeletal muscle. AMPK serves as your cellular energy sensor — when energy runs low, AMPK signals cells to switch from energy storage to energy production mode. Research suggests MOTS-c may help optimise this energy sensing system, ensuring more efficient metabolic regulation.

Once AMPK is activated, several beneficial cascades follow. Glucose uptake increases dramatically, particularly in muscle tissue, whilst insulin sensitivity improves. This is similar to how [Semaglutide](/peptides/semaglutide) improves glucose metabolism, but through entirely different pathways — MOTS-c works at the mitochondrial level rather than through GLP-1 receptors.

Data demonstrates that MOTS-c also disrupts folate metabolism in a controlled manner, specifically targeting AICAR transformylase, a key enzyme in the folate cycle. This interaction forces cells into a beneficial metabolic state — when folate cycling is disrupted, cells respond by increasing metabolic flexibility and efficiency. This stress-induced adaptation mechanism is similar to how controlled stress from exercise improves fitness.

Under metabolic stress conditions, evidence shows MOTS-c's unique nuclear translocation ability. The peptide can actually travel into the cell nucleus and bind to DNA regulatory sequences, directly influencing the expression of genes involved in stress adaptation and metabolic regulation. This dual cytoplasmic-nuclear function is unprecedented among therapeutic peptides and explains why MOTS-c effects are both immediate and long-lasting.

Another key mechanism involves mitochondrial biogenesis — investigations suggest MOTS-c may stimulate the production of new mitochondria whilst improving the function of existing ones. This is particularly relevant for ageing, as mitochondrial dysfunction is a hallmark of cellular senescence. The peptide's interaction with the folate cycle appears central to this process, as one-carbon metabolism is crucial for mitochondrial DNA synthesis and repair.

What makes MOTS-c especially interesting compared to growth hormone-releasing peptides like [CJC-1295](/peptides/cjc-1295) or [Ipamorelin](/peptides/ipamorelin) is its direct mitochondrial origin. Rather than manipulating hormone pathways, it works with your body's existing cellular communication systems to optimise energy production at the most fundamental level. For those interested in comprehensive mitochondrial support, our [peptide stacking guide](/learn/peptide-stacking) explores combining MOTS-c with other mitochondrial-supportive compounds.